Category Archives: "INforMS"

NeurologyLiveâ„¢ adds CMSC to its Strategic Alliance Partnership program
CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLiveâ„¢, a multimedia platform dedicated to providing health care professionals treating [...]
Kessler scientists receive grant to study exercise benefits in multiple sclerosis
East Hanover, NJ. October 7, 2019. With a grant from the Consortium of Multiple Sclerosis Centers, John DeLuca, PhD, Helen Genova, PhD, of [...]
EMD Serono initiates pivotal Phase III program for investigational Evobrutinib in RMS
ROCKLAND, Mass., Sept. 10, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. [...]
Genentech presents new six-year Ocrevus (Ocrelizumab) data
Post-hoc analysis from a Phase III open-label extension study showed a 42% reduction in the risk of PPMS patients needing a wheelchair [...]
Genentech’s Satralizumab significantly reduced relapse risk
Pivotal Phase III SAkuraStar study shows 55% reduction in the risk of relapse for satralizumab monotherapy versus placebo presented at [...]
Genentech presents new Ocrevus (Ocrelizumab) biomarker data
Blood neurofilament light chain (NfL) levels were significantly lowered following Ocrevus treatment in analyses of Phase III studies in RMS [...]
Dr. Daniel Kantor highlights multiple sclerosis treatments and what is in the pipeline
The field of treatments for multiple sclerosis (MS) has grown quickly in the last 30 years, but the next new class of therapies probably [...]
Multiple sclerosis relationships improved by togetherness and communication, study suggests
Relationships between multiple sclerosis patients and their intimate partners were enhanced when the couple worked together to make [...]
Press release – Genentech to present piviotal data at ECTRIMS
Investigational medicine satralizumab significantly reduces the risk of relapse in pivotal SAkuraStar monotherapy study for neuromyelitis [...]
Social cognition, mood and fatigue in multiple sclerosis
Study by MS research team links deficits in social cognition with fatigue, depressive symptomatology, and anxiety Date: August 29, [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM